To our knowledge, this is the first description of the successful induction of durable remission in a completely drug resistant, pediatric PICALM::MLLT10 + BCP-ALL by venetoclax, which was identified by individual ex vivo DRP. This evidence concerns the gene OPN1SW and acute lymphoblastic leukemia.